ALLOGENE THERAPEUTICS INC. - COMMON STOCK
2.1300
22-十一月-24 08:34:03
15 分钟延时
股票
+0.0200
+0.95%
今日范围
2.0900 - 2.1350
ISIN
N/A
来源
NASDAQ
-
Allogene Therapeutics Announces Participation in December Investor Conferences
19 11月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update
07 11月 2024 15:02:00 条件 Nasdaq GlobeNewswire
-
07 11月 2024 09:00:00 条件 Nasdaq GlobeNewswire
-
05 11月 2024 08:10:30 条件 Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in November Investor Conferences
04 11月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Allogene Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update
30 10月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in the Goldman Sachs Cell Therapy Day Conference
30 9月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
08 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Allogene Therapeutics Reports Second Quarter 2024 Financial Results and Business Update
07 8月 2024 15:02:54 条件 Nasdaq GlobeNewswire
-
Allogene Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update
31 7月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit
23 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
13 5月 2024 15:47:42 条件 Nasdaq GlobeNewswire
-
Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
13 5月 2024 15:01:00 条件 Nasdaq GlobeNewswire
-
Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
06 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
26 4月 2024 07:30:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >